Innovating the Future of Controlled Substance Waste Management
Real Change. Real Science. Real Results.
ONSITE DESTRUCTION WITHOUT INCINERATION
SafeMedWaste
CHEMICAL DIGESTION
$$$$
Reverse Distribution
+ INCINERATION
$$$$
STORAGE* Active
Disposal Product
+ INCINERATION
$$$$
product* Active-Bonded
STORAGE* Active-Bonded
TRANSPORT* Active-Bonded
STORAGE* Active-Bonded
A BETTER WAY TO MANAGE
The Big Risks of Small Molecules
Fast onsite chemical digestion of controlled substance wastage can lower costs, simplify handling processes, and reduce exposure to drug related risks of diversion, non-compliance, and environmental contamination.
Compatible drug wastage added to SafeMedWaste is immediately rendered non-retrievable, and fully destroyed in as little as 2 hours.*
*Destruction takes 2-24hrs for liquid wastage and up to 72hrs for solid wastage depending on drug state, type, volume, concentration, and combinations.
REAL CHANGE
REAL SCIENCE
REAL RESULTS
REAL CHANGE
Onsite disposal products that bond, adsorb, or sequester drug wastage often lack sufficient scientific data to support broad reaching claims of permanent and irreversible non-retrievability, drug destruction, and safety in the landfill environment. Risk-averse registrants frequently rely on offsite incineration for molecular destruction of their treated and untreated wastage. This more lengthy and complex process can result in a greater window of exposure to drug-related risks, and higher costs.
SafeMedWaste is scientifically proven to provide safe, complete, onsite molecular destruction of controlled substance wastage, without incineration. Real onsite chemical digestion that can take your drug wastage from active to non-existent in 72 hours or less.
Real Science
SafeMedWaste is a patented chemical digestion technology that quickly destroys the primary molecular bonds commonly found in most controlled substances. When used as directed, SafeMedWaste delivers reliable onsite destruction performance across a wide range of controlled substances.
The byproduct of the destruction process is pH-neutral, non-hazardous, no longer effective in humans and animals, and presents no risk of drug leaching in the landfill environment. The solidified waste contains no remnants, analogues, or derivatives that could be used to resynthesize the drug.
Fast, sustainable, onsite destruction just got real.
Real Results
When it comes to generating reliable and meaningful test data, not all test types or methods are created equally. That is why SafeMedWaste chose a well-recognized, independent, DEA-licensed laboratory to develop and execute a test plan that could ensure the safety and destruction efficacy of SafeMedWaste. Every controlled substance on the SafeMedWaste list of compatible drugs has successfully completed this stringent testing process.
Detailed test methods and results are available upon request to qualified interested parties. Test data includes results of HPLC-MS/MS and/or HPLC-DAD, TCLP, Method 1040, and Off-gassing studies.
About Us
SafeMedWaste™
The Eric Beddingfield Story: A Father's Journey of Heartbreak and Hope
Our Planet,
Our Commitment
SafeMedWaste is committed to innovation of sustainable products that help reduce or eliminate the release of harmful drug waste into our water systems and the environment.
News
NPR features Okra Medical on The South Carolina Business Review.
In an interview with Mike Switzer, the COO of Okra Medical talks about the company’s new onsite destruction product for dangerous drug wastage like opioids.
Information
Okra Medical Introduces SafeMedWaste
Innovating the Future of Controlled Substance Waste Management
Press Releases
Okra Medical Donates 3,000 Healthcare Masks To Tri-County Family Ministries In North Charleston
Charleston, S.C. (May 15, 2020) – Following a recent community neighborhood donation of 21,000 healthcare face masks, Okra Medical reached back out to U.S. Senator
OKRA MEDICAL NAMES BOARD OF ADVISORS
JOHNS ISLAND, SC, June 2019 – Okra Medical, an innovator in controlled substance disposal solutions, today announced the appointment of the following executives to its advisory
InnoVision Names Okra Medical As Award Finalist For Technology Development
INNOVISION PRESENTS OKRA MEDICAL WITH FINALIST AWARD FOR TECHNOLOGY DEVELOPMENT GREENVILLE, SC, November 22, 2019 – Okra Medical has received a 2019 InnoVision Finalist Award
